Abstract
Current Medicinal Chemistry - Anti-Cancer Agents
Title: Subject Index To Volume 2
Volume: 3Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Subject Index To Volume 2, Current Medicinal Chemistry - Anti-Cancer Agents 2003; 3 (1) .https://dx.doi.org/10.2174/1568011033353588
DOI https://dx.doi.org/10.2174/1568011033353588 | Print ISSN 1568-0118 |
Publisher Name Bentham Science Publisher | Online ISSN 1875-5968 |
Article Metrics
Related Articles
- Dimeric Approaches to Anti-Cancer Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Active-Targeted Nanotherapy Strategies for Prostate Cancer
Current Cancer Drug TargetsMolecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System
Current Pharmaceutical Design Fanconi Anemia Proteins, DNA Interstrand Crosslink Repair Pathways, and Cancer Therapy
Current Cancer Drug TargetsExploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine Tumors
Endocrine, Metabolic & Immune Disorders - Drug TargetsSesbania: A Prospective Candidate to be Excavated for Anticancer Drugs
The Natural Products JournalRisperidone: A Commentary on Drug Profiling
Current Drug Discovery TechnologiesEnvironmental Pollution and Asthma
Current Respiratory Medicine ReviewsThymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery TechnologiesPharmacophore Modeling and 3D QSAR Studies of Novel Human Carbonic Anhydrase IX Inhibitors
Letters in Drug Design & Discovery Squalamine: A Polyvalent Drug of the Future?
Current Cancer Drug TargetsMacromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal ChemistryChitosan Nano-encapsulation Enhances Gedunin Cytotoxicity A gainst Human Non-small-cell Lung Cancer (NCI-H292) Cell Line
Drug Delivery Letters The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer
Reviews on Recent Clinical TrialsCognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews Finding Drug Targets Through Analysis of the Platelet Transcriptome
Current Pharmaceutical DesignRecent Design and Structure-Activity Relationship Studies on the Modifications of DHFR Inhibitors as Anticancer Agents
Current Medicinal ChemistryFOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer
Current Cancer Drug TargetsPerspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design Apoptosis Pathways and Neuroblastoma Therapy
Current Pharmaceutical Design
[8]ページ先頭
©2009-2025 Movatter.jp